Skip to main content
main-content

Zeitschrift

Hepatology International

Hepatology International 1/2020

Ausgabe 1/2020

Inhaltsverzeichnis ( 15 Artikel )

21.11.2019 | Editorial | Ausgabe 1/2020

Change in antibiotic regimen for emerging multidrug resistance in nosocomial ascitic fluid infection

Seema Alam

21.11.2019 | Editorial | Ausgabe 1/2020

Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease

Yong-ho Lee, Seung Up Kim

04.12.2019 | Review Article | Ausgabe 1/2020

New drugs for NAFLD: lessons from basic models to the clinic

Katharina C. Reimer, Alexander Wree, Christoph Roderburg, Frank Tacke

03.12.2019 | Review Article | Ausgabe 1/2020 Open Access

Antimicrobial resistance in chronic liver disease

Vishal C. Patel, Roger Williams

19.11.2019 | Review Article | Ausgabe 1/2020

Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B

Lung-Yi Mak, Wai-Kay Seto, James Fung, Man-Fung Yuen

01.01.2020 | Original Article | Ausgabe 1/2020

Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure

Guojun Shen, Shuilin Sun, Jie Huang, Haohui Deng, Ying Xu, Zhanhui Wang, Xiong Tang, Xiaodong Gong

01.01.2020 | Original Article | Ausgabe 1/2020

Nucleoside analog monotherapy for prophylaxis in Hepatitis B liver transplant patients is safe and efficacious

Mark D. Muthiah, En Ying Tan, Sin Hui Melissa Chua, Daniel Q. Y. Huang, Glenn K. Bonney, Alfred W. C. Kow, Seng Gee Lim, Yock Young Dan, Poh Seng Tan, Guan Huei Lee, Boon Leng Lim

04.12.2019 | Original Article | Ausgabe 1/2020

Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging

Sunyoung Lee, Myeong-Jin Kim, Seung-seob Kim, Hyejung Shin, Do Young Kim, Jin-Young Choi, Mi-Suk Park, Donald G. Mitchell

04.12.2019 | Original Article | Ausgabe 1/2020

Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma

Jing Liao, Dan-Ni Zeng, Jin-Zhu Li, Qiao-Min Hua, Zhiyu Xiao, Chuanchao He, Kai Mao, Ling-Yan Zhu, Yifan Chu, Wei-Ping Wen, Limin Zheng, Yan Wu

01.01.2020 | Original Article | Ausgabe 1/2020

Improving pathological early diagnosis and differential biomarker value for hepatocellular carcinoma via RNAscope technology

Ahmed Musa Hago Bakheet, Chang Zhao, Jian-Ning Chen, Jing-Yue Zhang, Jun-Ting Huang, Yu Du, Li-Ping Gong, Yuan-Hua Bi, Chun-Kui Shao

01.01.2020 | Original Article | Ausgabe 1/2020

Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis

Min Li, Tingting Lv, Shanshan Wu, Wei Wei, Xiaohai Wu, Xiaojuan Ou, Hong Ma, Shein-Chung Chow, Yuanyuan Kong, Hong You, Jidong Jia

09.07.2019 | Original Article | Ausgabe 1/2020 Open Access

Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis

Changzhou Cai, Xin Song, Yishu Chen, Xueyang Chen, Chaohui Yu

01.01.2020 | Original Article | Ausgabe 1/2020 Open Access

Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease

Gema Gómez-Mariano, Nerea Matamala, Selene Martínez, Iago Justo, Alberto Marcacuzco, Carlos Jimenez, Sara Monzón, Isabel Cuesta, Cristina Garfia, María Teresa Martínez, Meritxell Huch, Ignacio Pérez de Castro, Manuel Posada, Sabina Janciauskiene, Beatriz Martínez-Delgado

09.07.2019 | Original Article | Ausgabe 1/2020

Ascitic fluid infection in children with liver disease: time to change empirical antibiotic policy

Sumit Kumar Singh, Ujjal Poddar, Richa Mishra, Anshu Srivastava, Surender Kumar Yachha

22.11.2019 | Original Article | Ausgabe 1/2020

TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad3, and NF-κB/NLRP3 inflammasome signaling pathways

Jing Zhao, Ming Han, Li Zhou, Pu Liang, Yun Wang, Shenghu Feng, Hongping Lu, Xiaoxue Yuan, Kai Han, Xiaofan Chen, Shunai Liu, Jun Cheng

Aktuelle Ausgaben

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise